Are there any side effects of BPC 157?

BPC 157 has several potential side effects and risks, particularly concerning tumor growth. According to Andrew Huberman, here are the main points to consider:

1. Angiogenesis and Tumor Risk: BPC 157 promotes angiogenesis (the formation of new blood vessels) by increasing vascular endothelial growth factor (VEGF). This mechanism is similar to some cancer treatments that inhibit VEGF to reduce tumor size. Thus, there's a risk that BPC 157 could potentially stimulate the growth of existing tumors or contribute to new tumor development. It may not be suitable for individuals with a history of cancer or concerns about tumors 1.

2. General Health Monitoring: Users are encouraged to take the minimal effective dose (typically 300-500 micrograms) and not to use it continuously or every day. Regular health monitoring is advisable to check for any signs of cancer or other health issues during its use 1.

3. Lack of Human Data: There is limited clinical data on the long-term effects of BPC 157 in humans, making caution important for anyone considering its use. While animal studies show promising results for tissue repair, the implications for human health remain uncertain 1.

In summary, while BPC 157 shows potential in enhancing recovery and healing, substantial risks concerning tumor development necessitate careful consideration and monitoring by users.